Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Home
Categories
- Consumer Goods
- Finance
- Health
- Industrials
- Technology
- Cannabis
Sequire Spotlight
Events

Sequire Spotlight Presents: OS Therapies (OSTX) – Creating Pharma Technology for Children with Cancer

Host Chris Miglino interviews CEO Paul Romness. He talks about the company going public, finishing their clinical trial and FDA approval.

Featured
Healthcare
November 12, 2024

Related Videos

Related Posts

Related Videos

Sequire Spotlight Presents: Ederra – World-First Farm-to-Body Functional Superfood Supplement November 19, 2024
Sequire Spotlight Presents: NewtekOne, Inc. (NEWT) – Providing Financial and Business Solutions November 12, 2024
Sequire Spotlight Presents: Beam Global (BEEM) – Sustainable Technology Innovation November 12, 2024
Sequire Spotlight Presents: NRX Pharmaceuticals Inc (NRXP) – Bringing Hope to Life July 01, 2024
Sequire Spotlight Presents: AnixaBiosciences – Immunotherapy to Prevent Cancer June 28, 2024
Sequire Spotlight Presents Tharimmune (THAR): Solving Problems for Patients with Liver Diseases June 20, 2024
Sequire Spotlight Presents: Navigating Health Insurance with GoHealth, Inc. (GOCO) April 02, 2024
Sequire Spotlight Presents Aethlon (AEMD): A Clinical Stage Medical Device Company August 22, 2023
Sequire Spotlight Presents Mednow (MDNWF): Disrupting the Pharma Industry August 22, 2023
Sequire Spotlight Presents Cingulate (CING): Single Administration to Optimize Patient Health-Care June 30, 2023

Related Post

Today’s Stock Market in 2-Minutes

July 21, 2026
Frontier Nuclear Launches Major 2026 Drill Program at the Pine Ridge Uranium Project

July 14, 2026
ZenaTech Signs Multiple Offers to Acquire Land Surveying and Geospatial Services Companies Across the U.S., Canada and Australia, Expected to Contribute C$40 Million in Revenue During the First 12 Months Following Closing

July 14, 2026
ZenaTech Reports Annualized Revenue Run Rate of Approximately CAD $33 Million Based on First Quarter 2026 Revenue

June 30, 2026

Microcaps.com is a trademark of SRAX, Inc.

Privacy Policy
Cookie Policy

About SRAX
About Sequire

We use cookies to improve your experience on our site, to show you personalized advertising, and as otherwise described in our Cookie Policy . To find out more, read our Privacy Policy and our Cookie Policy.